You are here
Amgen discounts cholesterol drug, but payers want more
AMGEN Inc sells its cholesterol-lowering drug Repatha at a discount of about 30 per cent to its US list price of US$14,000 a year, but the largest pharmacy benefit managers say they want lower prices after new data suggested more patients should be treated with the drug.
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org